跳至主要内容
临床试验/NCT01358370
NCT01358370已完成不适用

A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype

Alexion Pharmaceuticals, Inc.14 个研究点 分布在 5 个国家目标入组 40 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
14
主要终点
Time to Death

研究概览

简要总结

This is a Natural History study to characterize key aspects of the clinical course of lysosomal acid lipase (LAL) deficiency/Wolman phenotype in patients.

详细描述

The objective of this study is to characterize key aspects of the clinical course of LAL deficiency/Wolman phenotype in patients including, but not limited to, survival and growth parameters, to serve as a historical control to inform the evaluation and care of affected patients and to provide a reference for efficacy studies of enzyme replacement or other novel therapies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Deceased patients diagnosed with LAL deficiency/Wolman phenotype in 1985 or later provided they have required data points in their medical records.

排除标准

  • Patients will be excluded from the study if the required data points for inclusion are not available.
  • Living LAL deficiency/Wolman phenotype patients will be excluded

结局指标

主要结局

Time to Death

时间窗: Up to two years.

The time to death will be analyzed using Kaplan-Meier curves. Estimates (with exact 95% confidence interval \[CI\]) of the median and the lower and upper quartiles of time to death will be derived.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验